Bristol-Myers Claims Settlements Are Close In Lawsuits Over Generic Taxol, BuSpar
FDA Forms Office of Combination Products;
Obituary: Ellen Tobin, Consultant, Championed Patients’ Needs;
Report on Carcinogens Lists Estrogen, UV Light, Wood Dust;
Patent Policies Need Revision, Study of Hopkins, CellPro Dispute Concludes;
Funding Opportunities


Trending Stories
- Brawley: ACS prostate cancer screening guideline should say no to “mass screening”
- NCI’s Letai, FDA’s Diamantas identify strategies to speed up cancer trials
Letai: 150 days to start a cancer trial is too long—cancer centers need to accept a little risk - USPSTF convenes first meeting in over a year
- Cancer Grand Challenges awards $10M to research team aiming to develop AI “co-scientists”
AI agents would narrow the “incredibly large combinatorial universe of cancer questions” - Philadelphia cancer center directors talk city-wide collaboration
“A bench-to-bedside-to-block model” - The next revolution in cancer care may be manufactured at the bedside
As personalized mRNA cancer vaccines move toward clinical reality, the challenge will be to make them broadly available









